Frequency of Carbapenem Resistance in the Pathogenic Gram-Negative Bacteria from Hyderabad, Sindh: Carbapenem Resistance in the Pathogenic Gram-Negative Bacteria

Muhammad Akif Ilyas; Shaista Bano; Sarfraz Ali Tunio; Athar Ali Mangi; Hakim Detho

doi:10.54393/pjhs.v6i9.2080

Authors

Muhammad Akif Ilyas The Institute of Microbiology, University of Sindh, Jamshoro, Pakistan
Shaista Bano The Institute of Microbiology, University of Sindh, Jamshoro, Pakistan
Sarfraz Ali Tunio The Institute of Microbiology, University of Sindh, Jamshoro, Pakistan
Athar Ali Mangi The Institute of Microbiology, University of Sindh, Jamshoro, Pakistan
Hakim Detho The Institute of Microbiology, University of Sindh, Jamshoro, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v6i9.2080

Keywords:

Antibiotic Resistance, Carbapenems, Gram-Negative Bacteria, Pathogens

Abstract

Carbapenems are β-lactam antibiotics and are often used as a last resort to treat infections caused by the β-lactamase-producing Gram-negative bacteria owing to their ability to withstand hydrolysis by many β-lactamase enzymes. However, the emergence of carbapenem resistance in these pathogens has already been reported. In order to avoid critical situations for public health, regular monitoring and reporting of carbapenem resistance is essential. Objectives: To determine the frequency of carbapenem-resistant Gram-negative pathogens circulating in Hyderabad, Sindh. Methods: This cross-sectional study was carried out for one year. The clinical samples were collected using a convenience sampling technique from patients suspected of bacterial infections. The bacterial isolates were subjected to identification based on their microscopic, cultural, and biochemical characteristics. Sensitivity of each type of Gram-negative pathogen to antibiotics was established in terms of Clinical Laboratory Standards Institute guidelines, with the use of the Kirby-Bauer disk diffusion technique. Results: 400 clinical samples were randomly selected and they were divided into urine (n=212), pus (n=85), blood (n=68), and other (n=35). Their microbiological processing resulted in the recovery of two hundred seventy-seven isolates of Gram-negative bacteria identified as E. coli (31.05%), Enterobacter spp. (24.19%), Pseudomonas spp. (16.25%), Proteus spp. (14.44%), Klebsiella spp. (10.11%), and others (3.96%). The frequency of carbapenem-resistant isolates varied among species, with the highest prevalence in Pseudomonas spp. demonstrating 20% being carbapenem-resistant isolates. Conclusions: Carbapenem resistance in pathogenic Gram-negative bacteria has emerged. The development of carbapenem resistance in these pathogens can be catastrophic for public health.

Author Biography

Sarfraz Ali Tunio, The Institute of Microbiology, University of Sindh, Jamshoro, Pakistan

Professor, Director, Institute of Microbiology, University of Sindh, Jamshoro

References

Hawkey PM and Livermore DM. Carbapenem Antibiotics for Serious Infections. British Medical Journal. 2012 May; 344. doi: 10.1136/bmj.e3236.

Coulthurst SJ, Barnard AM, Salmond GP. Regulation and Biosynthesis of Carbapenem Antibiotics in Bacteria. Nature Reviews Microbiology. 2005 Apr; 3(4): 295-306. doi: 10.1038/nrmicro1128.

Armstrong T, Fenn SJ, Hardie KR. JMM Profile: Carbapenems: A Broad-Spectrum Antibiotic. Journal of Medical Microbiology. 2021 Dec; 70(12): 001462. doi: 10.1099/jmm.0.001462.

Codjoe FS and Donkor ES. Carbapenem Resistance: A Review. Medical Sciences. 2017 Dec; 6(1): 1. doi: 10.3390/medsci6010001.

Nordmann P and Poirel L. Epidemiology and Diagnostics of Carbapenem Resistance in Gram-Negative Bacteria. Clinical Infectious Diseases. 2019 Nov; 69(Supplement_7): S521-8. doi: 10.1093/cid/ciz824.

Dadgostar P. Antimicrobial Resistance: Implications and Costs. Infection and Drug Resistance. 2019 Dec: 3903-10. doi: 10.2147/IDR.S234610.

Tillotson GS and Zinner SH. Burden of Antimicrobial Resistance in an Era of Decreasing Susceptibility. Expert Review of Anti-Infective Therapy. 2017 Jul; 15(7): 663-76. doi: 10.1080/14787210.2017.1337508.

Hussain HI, Aqib AI, Seleem MN, Shabbir MA, Hao H, Iqbal Z et al. Genetic Basis of Molecular Mechanisms in Β-Lactam Resistant Gram-Negative Bacteria. Microbial Pathogenesis. 2021 Sep; 158: 105040. doi: 10.1016/j.micpath.2021.105040.

Patel G and Bonomo RA. Stormy Waters Ahead: Global Emergence of Carbapenemases. Frontiers in Microbiology. 2013 Mar; 4:48. doi: 10.3389/fmicb.2013.00048.

World Health Organization. Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug-Resistant Bacterial Infections, Including Tuberculosis. 2017.

Nanjundeswaraswamy TS and Divakar S. Determination of Sample Size and Sampling Methods in Applied Research. Proceedings on Engineering Sciences. 2021 Mar; 3(1): 25-32. doi: 10.3389/fmicb.2013.00048.

Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic Susceptibility Testing by A Standardized Single Disk Method. American Journal of Clinical Pathology. 1966 Apr; 45(4_ts): 493-6. doi: 10.1093/ajcp/45.4_ts.493.

Clinical and Laboratory Standard Institute (CLSI). Performance Standards for Anti-Microbial Susceptibility Testing. 30th Edition, M100. 2020.

Öztürk R and Murt A. Epidemiology of Urological Infections: A Global Burden. World Journal of Urology. 2020 Nov; 38(11): 2669-79. doi: 10.1007/s00345-019-03071-4.

Urooj S, Bano S, Tunio SA, Memon BA, Abbasi SM, Rajput Z. High Frequency of Gram-negative Bacilli (GNB) Pathogens in Wounds and Other Clinical Specimens: A Grave Public Health Concern. BioScientific Review. 2024 May; 6(2): 20-30. doi: 10.32350/bsr.62.2.

Abassi SM, Bano S, Tunio SA, Memon BA, Korejo IA. Frequency of Extended Spectrum Β Lactamases Producers in Gram-Negative Bacilli Pathogens. Rawal Medical Journal. 2024 Apr; 49(2): 255-.

Niranjan V and Malini A. Antimicrobial Resistance Pattern in Escherichia Coli Causing Urinary Tract Infection among Inpatients. Indian Journal of Medical Research. 2014 Jun; 139(6): 945-8.

Abro UA, Bano S, Tunio SA, Abassi SM. Antibiotic Resistance Trends in High-Risk Lineages of Salmonella Enterica Serovar Typhi: A Study Spanning Pre to Post COVID-19 Pandemic. Infection, Genetics and Evolution. 2024 Sep; 123: 105632. doi: 10.1016/j.meegid.2024.105632.

Detho H, Bano S, Tunio SA, Abbasi SM, Ahmed M. Biofilm Formation and Antibiotic Resistance in Uropathogenic Escherichia Coli: The Quest for Effective Treatment of Urinary Tract Infections. Pure and Applied Biology. 2023 Nov; 13(1): 38-46. doi: 10.19045/bspab.2024.130004.

Hauck C, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC et al. Spectrum of Excess Mortality Due to Carbapenem-Resistant Klebsiella Pneumoniae Infections. Clinical Microbiology and Infection. 2016 Jun; 22(6): 513-9. doi: 10.1016/j.cmi.2016.01.023.